Yi Pang

DNASE1L3 as a prognostic biomarker associated with immune cell infiltration in pancreatic cancer

Pancreatic adenocarcinoma (PAAD) is a highly aggressive malignancy, associated with a poor prognosis and a five-year survival rate of less than 9%. Although DNASE1L3 is known as an apoptosis-related gene, its specific role in cancer remains unclear. This study aimed to investigat...